Navigation Links
Phase I trial begins using gene therapy and bone marrow stem cells in the treatment of brain cancer
Date:11/14/2011

Cleveland, OH. and Gaithersburg, MD. University Hospitals (UH) Case Medical Center, Case Western Reserve University School of Medicine and Lentigen Corporation announced today the initiation of a novel Phase I clinical trial of LG631 gene therapy for the protection of hematopoietic stem cells (HSCs) from the dose limiting toxicity of chemotherapy with Temodar.

Approximately 17,000 Americans are diagnosed with glioblastoma every year and only two percent of them survive longer than five years even with aggressive treatment. Glioblastoma (GBM) treatment generally begins with a surgical resection, followed by radiation therapy and then chemotherapy to destroy any remaining cancer cells. Temodar (temozolomide, Merck and Co., Inc.) is a standard treatment of glioblastoma, but dose-limiting bone marrow toxicity often accompanies such therapy.

In this first-of-its-kind study, researchers are investigating if LG631 can potentially improve tolerance and effectiveness of chemotherapy for GBM by preventing damage to bone marrow. The study will evaluate the safety of this treatment and its potential to enhance current GBM treatments.

For this study, HSCs will be isolated from participating patients, transduced with LG631, an altered human-Methylguanine Methyltransferase (MGMT) gene to make them resistant to Temodar, and then infused back into the patient. The MGMT gene has been shown to repair damaged DNA. The specially designed Lentiviral vector (LG631) will be used to deliver the gene specifically to bone marrow stem cells that are susceptible to damage by drugs commonly used to treat cancer, thereby enabling patients to receive higher doses of Temodar with less severe side effects.

"Glioblastoma is a devastating disease and many patients do not benefit from standard therapy," notes Dr. Andrew Sloan, Director of the Brain Tumor and Neuro-Oncology Center, UH Case Medical Center and Associate Professor of Neurological Surgery and
'/>"/>

Contact: Alicia Reale
alicia.reale@uhhospitals.org
216-844-5156
University Hospitals Case Medical Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Phase III data show efficacy/safety of iclaprim in patients with complicated skin infections
2. Positive results in Phase 2 trial of treatment of C-difficile-associated diarrhea
3. NIH grants Phylonix Phase II SBIR to develop high-throughput in vivo zebrafish assays
4. Biolex presents Locteron US Phase 2a hepatitis C data at EASL
5. Cantabrian cornice has experienced seven cooling and warming phases over past 41,000 years
6. Resolvyx announces positive data -- Phase 2 trial of resolvin RX-10045 for dry eye syndrome
7. Scientists seek new emphases in Arctic climate change research
8. NIH funds new phase of high school-university research partnership
9. Registration Opens for Next Testing Phase of IEEE Certified Biometrics Professional Program
10. First phase of pan-tropical forest mapping debuting at COP15
11. ViroPharma Announces Initiation of Phase 2 Evaluation of Subcutaneous Delivery of Cinryze(TM) (C1 Esterase Inhibitor [Human])
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2014)... -- Leading Biometric companies aim to provide consumers ... transactions.  Companies in focus today are: NXT-ID, Inc. (NASDAQ: ... ), Google Inc. (NASDAQ: GOOG ), Microsoft Corporation ... EBAY ) and MasterCard Inc. (NYSE: MA) NXT-ID, ... authentication company focused on the growing mobile commerce is pleased ...
(Date:11/6/2014)... is an asset for a predator. Except when that predator ... tiger beetle, relative to its size, is the fastest creature ... body lengths per second (at about five miles per hour). ... take the sprinting gold from the tiger beetle, a person ... The tiger beetle has a problem. At peak speeds, everything ...
(Date:11/5/2014)... RENO – Kelly Redmond has dedicated his career ... knowledge to a general audience. , As deputy ... Climate Center at Nevada,s Desert Research Institute, Redmond ... the management, application and dissemination of climate data ... Annual Fall Meeting in San Francisco on December ...
Breaking Biology News(10 mins):Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 2Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 3Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 4Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 5Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 6The tiger beetle: Too fast to see 2Nevada climatologist to be honored at AGU Fall Meeting for lifetime of public outreach 2
... Learning more about the behavior of bed ... Agriculture (USDA) scientists to identify compounds to help control these ... decade has caused problems in major U.S. cities where they ... The small, blood-feeding insects are not known to transmit diseases, ...
... February 14 between 1:15 p.m., and 3:30 p.m. PST, ... Pregnancy Meeting , in San Francisco, California, researchers will ... (FER) have better outcomes compared to fresh in vitro ... general population. The study collected data from all ...
... Boston College biologist Ken Williams, whose research focuses on ... illnesses that strike people living with HIV and AIDS, ... the NIH,s National Institute of Neurological Disorders and Stroke. ... for Williams, research into monocyte and macrophage cells, which ...
Cached Biology News:Studying bed bug actions for new management tactics 2NIH grant funds Boston College research into illnesses afflicting people living with HIV 2
(Date:11/26/2014)... HOUSTON and PHILADELPHIA , ... the most demanding and unforgiving environments. Human exploration of ... cognitive performance to ensure mission safety and success, and ... cognitive performance for mission success, little is known about ... aspects of cognition are primarily affected. Now, ...
(Date:11/26/2014)... Winston-Salem, NC (PRWEB) November 26, 2014 ... Medical Advisory Board. PMG Research is a network of sites ... with access to over 2 million patient lives through its ... Research is comprised of 11 hub site locations in the ... , The first term of the board will ...
(Date:11/26/2014)... November 25, 2014 Continuing its award-winning ... earned three prestigious MarCom Awards for outstanding creative achievement ... a Platinum MarCom Award, the organization’s top honor, in ... St. Louis held in April of this year. The ... 14,000 attendees. Additionally, Nerium was awarded a Gold MarCom ...
(Date:11/26/2014)... SoundConnect , an award winning unified communications ... Darren Suders has joined the team as Director of ... partner program through innovative offerings, consistent partner ... brings more than 10-years of channel telecommunication experience to ... from policy development, to partner education and to expansion. ...
Breaking Biology Technology:Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts' Brain Function 2Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts' Brain Function 3Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts' Brain Function 4PMG Research Names Medical Advisory Board 2PMG Research Names Medical Advisory Board 3Nerium International™ Wins One Platinum, Two Gold MarCom Awards 2SoundConnect Appoints Director of Channel Development & Sales 2
... Biomarker for Prostate Cancer, ANN ARBOR, Mich., June ... profiling data and analysis tools, today,announced the central role ... of SPINK1 as a key new therapeutic target and,biomarker ... compendium of nearly 26,000 gene,expression and DNA copy number ...
... Chemetics(R) Technology to Lexicon Targets, COPENHAGEN, June ... with Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ) ... compounds for highly,validated drug targets., Under the ... technology will be applied to identify novel small ...
... Texas Oncology-Baylor Charles A.,Sammons Cancer Center, a ... Trial Participation Award at the recent 44th American ... The practice was one of,only 10 community oncology ... the fifth consecutive year that practices affiliated with ...
Cached Biology Technology:Oncomine(TM) Again Key to Prostate Cancer Discovery 2Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals 2Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals 3Texas Oncology-Baylor Sammons Cancer Center Recognized for Highest Commitment to Clinical Research at ASCO 2